CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.25 USD
+0.03 (2.46%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $1.24 -0.01 (-0.80%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.25 USD
+0.03 (2.46%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $1.24 -0.01 (-0.80%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Zacks News
Are Options Traders Betting on a Big Move in Co-Diagnostics (CODX) Stock?
by Zacks Equity Research
Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.
CoDiagnostics, Inc. (CODX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -25.00% and 40.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
CoDiagnostics Inc (CODX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CoDiagnostics Inc (CODX) closed at $17.11 in the latest trading session, marking a +0.38% move from the prior day.
Is Co-Diagnostics (CODX) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Company News for Apr 21, 2020
by Zacks Equity Research
Companies In The News Are: CYCC, CODX, NBY, EXEL
Implied Volatility Surging for Co-Diagnostics (CODX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.
Medical Services Outlook Bright Amid Coronavirus Crisis
by Urmimala Biswas
Despite the coronavirus-led worldwide sales disruption, medical services is one of the few sectors witnessing industry-wide growth right now.
Is Co-Diagnostics (CODX) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Zoom Video, CrowdStrike and Domino's
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Zoom Video, CrowdStrike and Domino's
Co-Diagnostics, Inc. (CODX) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Co-Diagnostics, Inc. (CODX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Sectors of Q1 & Their Winning Stocks
by Sanghamitra Saha
Inside the top-performing sectors of Q1 and their winning stocks.
Coronavirus Scare Supports These Biotech ETFs & Stocks
by Sanghamitra Saha
Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.
The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics
Coronavirus Test Kit Demand to Drive These 3 Stocks
by Zacks Equity Research
Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.
Has Co-Diagnostics (CODX) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals
4 Top Biotech Stocks to Buy in the Time of Coronavirus
by Tirthankar Chakraborty
We have picked biotech companies that are widely expected to develop a vaccine for the coronavirus and fight off the worst stock market carnage since the 2008 financial crisis.
The Zacks Analyst Blog Highlights: Netflix, Microsoft, Sempra Energy, Co-Diagnostics and Moderna
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Netflix, Microsoft, Sempra Energy, Co-Diagnostics and Moderna
Top Ranked Momentum Stocks to Buy for March 16th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 16th.
5 Smart Ways to Profit From the Coronavirus Crisis
by Tirthankar Chakraborty
Even though majority of investors are in a state of shock, many know how to profit during uncertain times like these. Here're five ways you can put your money to work amid the coronavirus outbreak.
Beat Virus With 2 Sector ETFs & Stocks That Survived 2008 Crisis
by Sanghamitra Saha
These two sectors lost lesser than the broader market during the 2008 financial crisis and may help you to tide over the latest virus crisis.
The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals
The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals
4 Stocks to Gain the Most From the Coronavirus Outbreak
by Nilanjan Banerjee
It is worthwhile to keep an eye on stocks of companies that are engaged in the prevention, diagnosis and treatment of the disease.
5 Stocks to Win Big From Trump's Economic Stimulus
by Tirthankar Chakraborty
Trump floats financial aids to counter the impact of the coronavirus outbreak. Notable stimulus measures include payroll tax cut, aid for wage earners and an emergency funding worth $8.3 billion